Cargando…

The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis

Low skeletal muscle mass (LSMM) is increasingly recognized for its predictive value for adverse events in cancer patients. In specific, the predictive value of LSMM has been demonstrated for anti-cancer drug toxicity in a variety of cancer types and anti-cancer drugs. However, due to the limited sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huiskamp, Laura F. J., Chargi, Najiba, Devriese, Lot A., May, Anne M., Huitema, Alwin D. R., de Bree, Remco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700117/ https://www.ncbi.nlm.nih.gov/pubmed/33238530 http://dx.doi.org/10.3390/jcm9113780

Ejemplares similares

Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy
por: Chargi, Najiba, et al.
Publicado: (2021)

The association of pretreatment low skeletal muscle mass with chemotherapy dose‐limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high‐dose cisplatin
por: Bril, Sandra I., et al.
Publicado: (2021)

The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
por: Huiskamp, L. F. J., et al.
Publicado: (2020)

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients
por: de Jong, Corine, et al.
Publicado: (2022)

Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer
por: Chargi, Najiba, et al.
Publicado: (2022)

Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
por: Meerkerk, C. D. A., et al.
Publicado: (2021)

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
por: Schaeffers, Anouk W. M. A., et al.
Publicado: (2023)

Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics
por: Molenaar‐Kuijsten, Laura, et al.
Publicado: (2021)

Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy
por: Bril, Sandra I., et al.
Publicado: (2021)

Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathways
por: Hiensch, Anouk E., et al.
Publicado: (2019)

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
por: Kurk, Sophie, et al.
Publicado: (2019)

Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy
por: Bril, Sandra I., et al.
Publicado: (2019)

First experiences with (177)Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer
por: Klein Nulent, Thomas J. W., et al.
Publicado: (2021)

Reference Values for Skeletal Muscle Mass – Current Concepts and Methodological Considerations
por: Walowski, Carina O., et al.
Publicado: (2020)

Appendicular Skeletal Muscle Mass Reference Values and the Peak Muscle Mass to Identify Sarcopenia among Iranian Healthy Population
por: Shafiee, Gita, et al.
Publicado: (2018)

Age- and gender-dependent values of skeletal muscle mass in healthy children and adolescents
por: Webber, Colin E., et al.
Publicado: (2011)

The Reference Value of Skeletal Muscle Mass Index for Defining the Sarcopenia of Women in Korea
por: Kwon, Hyoung-Joon, et al.
Publicado: (2015)

Diagnostic and Treatment-Related Challenges in Sinonasal Teratocarcinosarcoma: A Report of Three Cases
por: Scheurleer, W. F. Julius, et al.
Publicado: (2023)

Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer
por: Chargi, N., et al.
Publicado: (2019)

Perspective on the Assessment of Skeletal Muscle Mass
por: Arai, Hidenori
Publicado: (2023)

Reference values for skeletal muscle mass and fat mass measured by bioelectrical impedance in 390 565 UK adults
por: Lee, Mei‐Man, et al.
Publicado: (2020)

Cutoff values for appendicular skeletal muscle mass and strength in relation to fear of falling among Brazilian older adults: cross-sectional study
por: Sampaio, Ricardo Aurélio Carvalho, et al.
Publicado: (2017)

Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil
por: Schmulenson, Eduard, et al.
Publicado: (2022)

The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour
por: de Bree, Remco
Publicado: (2010)

Effect of Skeletal Muscle and Fat Mass on Muscle Strength in the Elderly
por: Nonaka, Koji, et al.
Publicado: (2018)

Signaling pathways controlling skeletal muscle mass
por: Egerman, Marc A., et al.
Publicado: (2014)

Lipid modulation of skeletal muscle mass and function
por: Lipina, Christopher, et al.
Publicado: (2016)

Impact of Skeletal Muscle Mass on Metabolic Health
por: Kim, Gyuri, et al.
Publicado: (2020)

Menopause and the Loss of Skeletal Muscle Mass in Women
por: KO, Jupil, et al.
Publicado: (2021)

Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principle
por: El Amrani, Mohsin, et al.
Publicado: (2019)

Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC
por: Mallet, R., et al.
Publicado: (2021)

Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra
por: Bril, S. I., et al.
Publicado: (2019)

Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients
por: Kurk, Sophie A, et al.
Publicado: (2019)

Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients
por: Kurk, Sophie A., et al.
Publicado: (2018)

Evaluation of an alternative skeletal muscle index for skeletal muscle mass assessment in a group of Australian women
por: Yee, Ming Li, et al.
Publicado: (2022)

Lower Extremity Skeletal Muscle Mass, but Not Upper Extremity Skeletal Muscle Mass, Is Inversely Associated with Hospitalization in Patients with Type 2 Diabetes
por: Hamasaki, Hidetaka
Publicado: (2017)

Regulation of Skeletal Muscle Oxidative Capacity and Muscle Mass by SIRT3
por: Lin, Ligen, et al.
Publicado: (2014)

The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis
por: Jaiswal, N., et al.
Publicado: (2019)

The effects of ketogenic dieting on skeletal muscle and fat mass
por: Rauch, Jacob T, et al.
Publicado: (2014)

New Skeletal Muscle Mass Index in Diagnosis of Sarcopenia
por: Moon, Jeong Jae, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8s13f49pkttnhsm5eokctkskpk